Your browser doesn't support javascript.
loading
Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil.
Terakura, S; Wake, A; Inamoto, Y; Murata, M; Sakai, R; Yamaguchi, T; Takahashi, S; Uchida, N; Onishi, Y; Ohashi, K; Ozawa, Y; Kanamori, H; Yamaguchi, H; Fukuda, T; Ichinohe, T; Takanashi, M; Atsuta, Y; Teshima, T.
Afiliação
  • Terakura S; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Wake A; Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan.
  • Inamoto Y; Okinaka Memorial Institute of Medical Research, Tokyo, Japan.
  • Murata M; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Sakai R; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Yamaguchi T; Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Takahashi S; Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Uchida N; Department of Cell Processing and Transfusion, Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Onishi Y; Okinaka Memorial Institute of Medical Research, Tokyo, Japan.
  • Ohashi K; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
  • Ozawa Y; Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan.
  • Kanamori H; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Yamaguchi H; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
  • Fukuda T; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Ichinohe T; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Takanashi M; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Atsuta Y; Department of Hematology and Oncology, Hiroshima University Hospital, Hiroshima, Japan.
  • Teshima T; Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
Bone Marrow Transplant ; 52(3): 423-430, 2017 Mar.
Article em En | MEDLINE | ID: mdl-27941766

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metotrexato / Transplante de Células-Tronco de Sangue do Cordão Umbilical / Doença Enxerto-Hospedeiro / Ácido Micofenólico Tipo de estudo: Clinical_trials / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metotrexato / Transplante de Células-Tronco de Sangue do Cordão Umbilical / Doença Enxerto-Hospedeiro / Ácido Micofenólico Tipo de estudo: Clinical_trials / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão